betamethasone-17,21-dipropionate has been researched along with Candidiasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Emgård, P; Hellström, S; Holm, S | 1 |
Feldman, SR; Fleischer, AB; Shaffer, MP | 1 |
Dan, M | 1 |
3 other study(ies) available for betamethasone-17,21-dipropionate and Candidiasis
Article | Year |
---|---|
External otitis caused by infection with Pseudomonas aeruginosa or Candida albicans cured by use of a topical group III steroid, without any antibiotics.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Betamethasone; Candidiasis; Colony-Forming Units Assay; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ear Canal; Hydrocortisone; Male; Otitis Externa; Oxytetracycline; Polymyxin B; Pseudomonas Infections; Rats; Treatment Outcome | 2005 |
Use of clotrimazole/betamethasone diproprionate by family physicians.
Topics: Administration, Topical; Adult; Age Factors; Ambulatory Care; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Child, Preschool; Clotrimazole; Cost Savings; Demography; Dermatology; Drug Combinations; Drug Costs; Drug Prescriptions; Drug Utilization; Family Practice; Female; Glucocorticoids; Humans; Male; Middle Aged; Mycoses; Pediatrics; United States | 2000 |
Severe vulvovaginitis associated with intravaginal nystatin therapy.
Topics: Administration, Intravaginal; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Edema; Erythema; Female; Humans; Hydrocortisone; Middle Aged; Nystatin; Vulvovaginitis | 2001 |